Close Menu

legal settlement

The suit was filed in early November and accused PacBio of luring away at least 15 of Affymetrix's former employees.

The offer was extended to Dec. 16, so investors can consider disclosures in an amended SEC filing related to a settlement with shareholders.

Proteome Sciences had sued Sanofi-Aventis for breach of contract and statutory obligations in connection to a sales and transfer agreement which concerned a share and a limited partnership interest in Xzillion Proteomics.

The firm also raised around $1.7 million through a warrant conversion tied to a 2007 private placement.

The settlement ends a dispute over distribution rights to two DxS assays, with both firms having the right to distribute the products.

The EraGen license comes a couple of days after Gen-Probe took a license to the same non-coding patents.

Sequenom agreed to pay shareholders $14 million to settle a class action suit filed months after the firm's stock plummeted in the wake of an announcement regarding the mishandling of data on the firm's SEQureDx test.

Gen-Probe is one of several firms that were sued by Genetic Technologies in February for alleged infringement of a patent covering methods of analyzing non-coding DNA sequences.

The settlement will provide Celera with at least $7 million from the defendants in the litigation, and sets certain prohibitions, such as the soliciting or hiring of Berkeley HeartLab employees.

Shimadzu denied infringing the patents, but it agreed to discontinue sales of the MultiNA system in the US.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.